Online inquiry

IVTScrip™ mRNA-Human ADAMTS17, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK14301MR)

This product GTTS-WK14301MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ADAMTS17 protein. This product can be used in Oogenesis phase fetal germ cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 1
Species Human
RefSeq NM_139057.4
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 170691
UniProt ID Q8TE56
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ADAMTS17, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) (GTTS-WK14301MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTTS-WK22958MR IVTScrip™ mRNA-Human ARMC9, (Cap 0, 5-Methyl-CTP, 120 nt-poly(A)) mRNA ARMC9
GTTS-WK17311MR IVTScrip™ mRNA-Human ANKRD26P1, (Cap 0, 2-Thio-UTP, 30 nt-poly(A)) mRNA ANKRD26P1
GTTS-WK28296MR IVTScrip™ mRNA-Human ARHGAP32, (Cap 1, 5-Methyl-CTP, 30 nt-poly(A)) mRNA ARHGAP32
GTTS-WK17303MR IVTScrip™ mRNA-Human ANKRD17, (Cap 0, 2-Thio-UTP, 30 nt-poly(A)) mRNA ANKRD17
GTTS-WK8000MR IVTScrip™ mRNA-Human ADAMTS16, (Cap 0, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA ADAMTS16
GTTS-WK10399MR IVTScrip™ mRNA-Human ADAMTS14, (Cap 0, 5-Methyl-CTP, 30 nt-poly(A)) mRNA ADAMTS14
GTTS-WK15746MR IVTScrip™ mRNA-Human AMBN, (Cap 0, 5-Methyl-CTP, 120 nt-poly(A)) mRNA AMBN
GTTS-WK15023MR IVTScrip™ mRNA-Human AHNAK2, (Cap 0, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA AHNAK2
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10 AM EDT | May 19, 2026

Register Now →